NRC Health (NRC) stock
NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3081% above fair value
$26.56−0.08 (-0.30%)
Close on Nov 13, 2026Market cap $587.50MP/E –Yield 1.96%
NRC Health operating margin
Operating margin is operating income as a percentage of revenue.
NRC Health's operating margin for the twelve months ending Sep 30, 2026 was 11.1%. For fiscal 2025 it was 16.4%, against 24.6% the year before. The highest annual figure on record is 34.0% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 16.4% | −8.2 |
| FY2024 | Dec 31, 2024 | 24.6% | −2.4 |
| FY2023 | Dec 31, 2023 | 27.0% | −3.8 |
| FY2022 | Dec 31, 2022 | 30.7% | −3.3 |
| FY2021 | Dec 31, 2021 | 34.0% | +2.0 |
| FY2020 | Dec 31, 2020 | 32.0% | −1.6 |
| FY2019 | Dec 31, 2019 | 33.6% | +4.2 |
| FY2018 | Dec 31, 2018 | 29.5% | +0.4 |
| FY2017 | Dec 31, 2017 | 29.1% | +0.6 |
| FY2016 | Dec 31, 2016 | 28.5% | +2.7 |
| FY2015 | Dec 31, 2015 | 25.8% | −2.8 |
| FY2014 | Dec 31, 2014 | 28.6% | +1.8 |
| FY2013 | Dec 31, 2013 | 26.8% | +0.5 |
| FY2012 | Dec 31, 2012 | 26.3% | +1.6 |
| FY2011 | Dec 31, 2011 | 24.7% | +2.9 |
| FY2010 | Dec 31, 2010 | 21.9% | −1.9 |
| FY2009 | Dec 31, 2009 | 23.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 23.2% | +0.8 |
| Q2 FY2026 | Jun 30, 2026 | -9.1% | −13.8 |
| Q1 FY2026 | Mar 31, 2026 | 16.0% | −9.6 |
| Q4 FY2025 | Dec 31, 2025 | 13.3% | −12.7 |
| Q3 FY2025 | Sep 30, 2025 | 22.4% | +0.1 |
| Q2 FY2025 | Jun 30, 2025 | 4.7% | −20.6 |
| Q1 FY2025 | Mar 31, 2025 | 25.6% | +0.8 |
| Q4 FY2024 | Dec 31, 2024 | 26.0% | −4.8 |
| Q3 FY2024 | Sep 30, 2024 | 22.3% | −4.0 |
| Q2 FY2024 | Jun 30, 2024 | 25.3% | −0.6 |
| Q1 FY2024 | Mar 31, 2024 | 24.8% | +0.1 |
| Q4 FY2023 | Dec 31, 2023 | 30.8% | −1.3 |
| Q3 FY2023 | Sep 30, 2023 | 26.2% | −3.2 |
| Q2 FY2023 | Jun 30, 2023 | 25.9% | −4.9 |
| Q1 FY2023 | Mar 31, 2023 | 24.7% | −5.7 |
| Q4 FY2022 | Dec 31, 2022 | 32.1% | −1.5 |
| Q3 FY2022 | Sep 30, 2022 | 29.5% | −5.3 |
| Q2 FY2022 | Jun 30, 2022 | 30.8% | −2.8 |
| Q1 FY2022 | Mar 31, 2022 | 30.4% | −3.5 |
| Q4 FY2021 | Dec 31, 2021 | 33.6% | +4.3 |
| Q3 FY2021 | Sep 30, 2021 | 34.8% | −1.1 |
| Q2 FY2021 | Jun 30, 2021 | 33.6% | +3.8 |
| Q1 FY2021 | Mar 31, 2021 | 33.9% | +0.8 |
| Q4 FY2020 | Dec 31, 2020 | 29.3% | −7.4 |
| Q3 FY2020 | Sep 30, 2020 | 35.9% | +4.4 |
| Q2 FY2020 | Jun 30, 2020 | 29.8% | −2.5 |
| Q1 FY2020 | Mar 31, 2020 | 33.1% | −0.9 |
| Q4 FY2019 | Dec 31, 2019 | 36.7% | +6.0 |
| Q3 FY2019 | Sep 30, 2019 | 31.5% | +0.9 |
| Q2 FY2019 | Jun 30, 2019 | 32.3% | +4.6 |
| Q1 FY2019 | Mar 31, 2019 | 34.0% | +5.1 |
| Q4 FY2018 | Dec 31, 2018 | 30.7% | +1.7 |
| Q3 FY2018 | Sep 30, 2018 | 30.5% | +5.9 |
| Q2 FY2018 | Jun 30, 2018 | 27.7% | −2.0 |
| Q1 FY2018 | Mar 31, 2018 | 28.9% | −4.1 |
| Q4 FY2017 | Dec 31, 2017 | 29.0% | −2.2 |
| Q3 FY2017 | Sep 30, 2017 | 24.6% | – |
| Q2 FY2017 | Jun 30, 2017 | 29.7% | – |
| Q1 FY2017 | Mar 31, 2017 | 33.0% | – |
| Q4 FY2016 | Dec 31, 2016 | 31.1% | – |
See a number that looks wrong?